This article relies largely or entirely on a single source. (December 2018) |
Paul Kielholz (15 November 1916 – 25 May 1990) was a Swiss psychiatrist, known mainly for his work on major depression, for example, for his method of overcoming antidepressant resistance by using simultaneous intravenous infusions of clomipramine and maprotiline, together with sulpiride and benzodiazepines.[1] He was born in 1916 in Switzerland.
References
edit- ^ Kielholz, P; Terzani, S; Gastpar, M; Adams, C (22 May 1981). "Behandlung therapieresistenter Depressionen ohne Elektroschock" [Management of treatment-resistant depression without ECT (author's transl)]. Deutsche Medizinische Wochenschrift (in German). 106 (21): 671–673. doi:10.1055/s-2008-1070377. PMID 6113126.
 | This biographical article about a scientist is a stub. You can help Wikipedia by expanding it. |